Zydus Lifesciences Ltd (BOM:532321)
₹ 964.4 -8.55 (-0.88%) Market Cap: 970.41 Bil Enterprise Value: 965.67 Bil PE Ratio: 22.61 PB Ratio: 4.45 GF Score: 97/100

Q3 2021 Cadila Healthcare Ltd Earnings Call Transcript

Feb 05, 2021 / 11:00AM GMT
Release Date Price: ₹475.4 (-0.78%)
Operator

Ladies and gentlemen, good day, and welcome to Cadila Healthcare Limited Q3 FY '21 Earnings Conference Call. (Operator Instructions) I now hand the conference over to Mr. Ganesh Nayak, COO and Executive Director from Cadila Healthcare Limited. Thank you, and over to you.

Ganesh Narayan Nayak
Cadila Healthcare Limited - COO & Executive Director

Good evening, ladies and gentlemen. Welcome to our post results teleconference for the quarter ended December 31, 2020. I do wish that you and your family continue to remain safe and healthy during these times. For today's call, we have with us Dr. Sharvil Patel, Managing Director; Mr. Nitin Parekh, Chief Financial Officer; Mr. Harish Sadana, Chief Strategy Officer; and Mr. Vishal Gor, Senior Vice President, Corporate Finance.

While 2020 turned out to be one of the most challenging years for people across the globe on account of the unabated spread of COVID-19, 2021 offers new hope to humanity as various countries have now seen success in the development of vaccines to combat the pandemic. With that, let me

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot